University of Applied Sciences and Arts of Southern Switzerland
Who can join
Adults 18 to 35, female only, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Maximum Voluntary Isometric Contraction (N)Primary· baseline to 72 hours
maximun voluntary isometric contraction of the knee extensor muscle will be assessed.
BL
Group
Value
95% CI
Repeated Cold-water Immersion
54.8
± 14.9
Repeated Warm-water Immersion
65.8
± 11.6
Control
52.2
± 14.1
24h
Group
Value
95% CI
Repeated Cold-water Immersion
33.8
± 13.9
Repeated Warm-water Immersion
41.1
± 11.4
Control
29.3
± 8.7
48h
Group
Value
95% CI
Repeated Cold-water Immersion
41.8
± 16.4
Repeated Warm-water Immersion
47.9
± 10.3
Control
34.7
± 12.3
72h
Group
Value
95% CI
Repeated Cold-water Immersion
45.0
± 17.0
Repeated Warm-water Immersion
54.5
± 11.8
Control
40.4
± 13.2
Delayed Onset of Muscle Soreness (DOMS)Primary· baseline to 72 hours
delayed onset of muscle soreness will be measured using a 0-10 scale, where 0 indicated no soreness and 10 indicates maximum soreness of the knee extensor muscles
BL
Group
Value
95% CI
Repeated Cold-water Immersion
0.1
± 0.1
Repeated Warm-water Immersion
0.1
± 0.1
Control
0.1
± 0.1
24h
Group
Value
95% CI
Repeated Cold-water Immersion
6.3
± 2.6
Repeated Warm-water Immersion
6.1
± 2.5
Control
6.3
± 2.7
48h
Group
Value
95% CI
Repeated Cold-water Immersion
5.0
± 2.8
Repeated Warm-water Immersion
5.9
± 3.0
Control
6.1
± 3.1
72h
Group
Value
95% CI
Repeated Cold-water Immersion
2.9
± 2.6
Repeated Warm-water Immersion
4.6
± 3.1
Control
3.3
± 2.3
Muscle SwellingPrimary· baseline to 72 hours
swelling of the knee extensor muscle will be performed using a ultrasound device.
BL
Group
Value
95% CI
Repeated Cold-water Immersion
4.3
± 0.5
Repeated Warm-water Immersion
4.8
± 0.6
Control
4.6
± 0.5
24h
Group
Value
95% CI
Repeated Cold-water Immersion
4.6
± 0.5
Repeated Warm-water Immersion
5.2
± 0.6
Control
4.8
± 0.6
48h
Group
Value
95% CI
Repeated Cold-water Immersion
4.5
± 0.5
Repeated Warm-water Immersion
5.1
± 0.5
Control
4.7
± 0.6
72h
Group
Value
95% CI
Repeated Cold-water Immersion
4.4
± 0.5
Repeated Warm-water Immersion
5.0
± 0.6
Control
4.6
± 0.6
Creatine-kinase (U/l)Primary· baseline to 72 hours
using a blood sample (6 ml), creatine-kinase will be assessed
BL
Group
Value
95% CI
Repeated Cold-water Immersion
111.0
± 41.5
Repeated Warm-water Immersion
214.3
± 180.9
Control
119.8
± 50.2
24h
Group
Value
95% CI
Repeated Cold-water Immersion
573.5
± 488.9
Repeated Warm-water Immersion
820.6
± 517.7
Control
455.0
± 318.2
48h
Group
Value
95% CI
Repeated Cold-water Immersion
335.4
± 256.9
Repeated Warm-water Immersion
441.2
± 349.2
Control
288.3
± 200.9
72h
Group
Value
95% CI
Repeated Cold-water Immersion
205.9
± 146.2
Repeated Warm-water Immersion
314.3
± 321.8
Control
191.4
± 118.1
Muscle Blood OxygenationPrimary· through recovery intervention up to 30 minutes
Muscle oxygenation saturation (SmO2) of the knee extensor muscle will be measured using near-infrared spectroscopy device. Oxygenated haemoglobin (oxyHb), deoxygenated haemoglobin (deoxyHb) and total haemoglobin (TotHb) were assessed in arbitrary units and SmO2 was calculated as oxyHb/TotHb x 100 value (%)
BL
Group
Value
95% CI
Repeated Cold-water Immersion
68.7
± 4.4
Repeated Warm-water Immersion
68.8
± 3.8
Control
70.0
± 3.7
post exercise
Group
Value
95% CI
Repeated Cold-water Immersion
70.4
± 7.7
Repeated Warm-water Immersion
71.1
± 7.1
Control
73.4
± 5.9
post Intervention
Group
Value
95% CI
Repeated Cold-water Immersion
76.6
± 5.8
Repeated Warm-water Immersion
76.6
± 3.4
Control
74.0
± 4.8
10min
Group
Value
95% CI
Repeated Cold-water Immersion
73.6
± 5.3
Repeated Warm-water Immersion
75.5
± 5.1
Control
75.0
± 5.4
20min
Group
Value
95% CI
Repeated Cold-water Immersion
67.8
± 2.7
Repeated Warm-water Immersion
74.7
± 3.2
Control
73.5
± 6.6
30min
Group
Value
95% CI
Repeated Cold-water Immersion
64.4
± 6.4
Repeated Warm-water Immersion
74.4
± 3.9
Control
73.0
± 6.1
Skin Temperature (°C)Primary· through recovery intervention up to 30 minutes
Skin temperature will be measured using a near infrared thermography camera
BL
Group
Value
95% CI
Repeated Cold-water Immersion
30.6
± 0.9
Repeated Warm-water Immersion
31.2
± 1.1
Control
30.9
± 0.9
post Exercise
Group
Value
95% CI
Repeated Cold-water Immersion
30.0
± 0.9
Repeated Warm-water Immersion
29.9
± 1.0
Control
29.5
± 1.7
post Intervention
Group
Value
95% CI
Repeated Cold-water Immersion
15.2
± 2.5
Repeated Warm-water Immersion
35.2
± 0.7
Control
31.8
± 1.0
10min
Group
Value
95% CI
Repeated Cold-water Immersion
24.8
± 1.2
Repeated Warm-water Immersion
35.3
± 0.5
Control
32.3
± 0.8
20min
Group
Value
95% CI
Repeated Cold-water Immersion
27.9
± 1.1
Repeated Warm-water Immersion
34.9
± 0.5
Control
32.4
± 0.8
30min
Group
Value
95% CI
Repeated Cold-water Immersion
29.2
± 1.0
Repeated Warm-water Immersion
34.8
± 0.7
Control
32.5
± 0.9
Core Temperature (°C)Primary· through recovery intervention up to 30 minutes
core temperature will be measured using temperature pill that will provide real time values from the gastrointestinal region
BL
Group
Value
95% CI
Repeated Cold-water Immersion
37.1
± 0.4
Repeated Warm-water Immersion
37.1
± 0.2
Control
36.8
± 0.4
post Exercise
Group
Value
95% CI
Repeated Cold-water Immersion
38.5
± 0.2
Repeated Warm-water Immersion
38.4
± 0.3
Control
38.3
± 0.2
post Intervention
Group
Value
95% CI
Repeated Cold-water Immersion
37.9
± 0.2
Repeated Warm-water Immersion
38.5
± 0.3
Control
37.9
± 0.3
10 min
Group
Value
95% CI
Repeated Cold-water Immersion
37.6
± 0.2
Repeated Warm-water Immersion
37.8
± 0.2
Control
37.5
± 0.2
20 min
Group
Value
95% CI
Repeated Cold-water Immersion
37.3
± 0.2
Repeated Warm-water Immersion
37.5
± 0.2
Control
37.3
± 0.2
30 min
Group
Value
95% CI
Repeated Cold-water Immersion
37.2
± 0.2
Repeated Warm-water Immersion
37.5
± 0.2
Control
37.2
± 0.1
Sponsor's own description
The overall aim of this study is, to evaluate the effectiveness of repeated cold- and warm water immersion on performance recovery after muscle damage.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
NCT06707207 — Predicting Future Errors During Skill Performance
· recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
· Phase 1
· recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease.
· NA
· recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects
· NA
· recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity
· Phase 1, PHASE2
· recruiting
Other University of Applied Sciences and Arts of Southern Switzerland trials
Trials by the same sponsor.
NCT06813690 — Effects of Immediate and Delayed Repeated Cold Exposure After Physical Exertion
· NA
· completed
NCT06852872 — The Effect of Diathermy Therapy on Isolated Lumbar Extension (ILEX) Training
· NA
· completed
NCT05395273 — Cryocompression After Total Knee Arthroplasty
· NA
· completed
NCT04075565 — The Psychophysiological Effect of Simulated and Terrestrial Altitude
· NA
· completed
NCT03689400 — Changes of Pain and Functional Parameters in Back Pain Patients Over Time
· completed
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Applied Sciences and Arts of Southern Switzerland
Last refreshed: 7 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04902924.